Patricia Formento

3.6k total citations
78 papers, 2.8k citations indexed

About

Patricia Formento is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Patricia Formento has authored 78 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 28 papers in Molecular Biology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Patricia Formento's work include Colorectal Cancer Treatments and Studies (31 papers), Cancer Treatment and Pharmacology (21 papers) and HER2/EGFR in Cancer Research (16 papers). Patricia Formento is often cited by papers focused on Colorectal Cancer Treatments and Studies (31 papers), Cancer Treatment and Pharmacology (21 papers) and HER2/EGFR in Cancer Research (16 papers). Patricia Formento collaborates with scholars based in France, Italy and Belgium. Patricia Formento's co-authors include G. Milano, Jean–Louis Fischel, M C Etienne, Nicolas Magné, N. Renée, M Francoual, Marie-Christine Étienne-Grimaldi, J-L Fischel, F Démard and Jean–Louis Formento and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Patricia Formento

78 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia Formento France 29 1.8k 991 836 393 333 78 2.8k
M Francoual France 28 1.5k 0.8× 729 0.7× 682 0.8× 327 0.8× 305 0.9× 60 2.2k
Dennis Salonga United States 24 2.1k 1.1× 1.4k 1.5× 1.2k 1.4× 546 1.4× 630 1.9× 33 3.4k
Shiu‐Feng Huang Taiwan 29 1.2k 0.7× 1.4k 1.4× 944 1.1× 596 1.5× 144 0.4× 78 2.9k
Paul Frankel United States 34 1.9k 1.1× 1.8k 1.8× 967 1.2× 658 1.7× 337 1.0× 214 4.1k
Marie-Christine Étienne-Grimaldi France 27 1.3k 0.7× 722 0.7× 508 0.6× 343 0.9× 242 0.7× 82 1.9k
Edward M. Newman United States 26 1.2k 0.6× 1.1k 1.1× 431 0.5× 199 0.5× 391 1.2× 88 2.4k
Hiroyasu Kaneda Japan 30 2.3k 1.3× 1.1k 1.1× 1.6k 1.9× 445 1.1× 284 0.9× 118 3.5k
Jean–Louis Fischel France 24 1.2k 0.7× 817 0.8× 599 0.7× 348 0.9× 140 0.4× 62 1.9k
Wing‐Kai Chan Taiwan 22 1.4k 0.8× 1.4k 1.4× 1.2k 1.4× 828 2.1× 203 0.6× 57 3.2k
Fulvio Lonardo United States 32 1.4k 0.8× 1.3k 1.4× 1.4k 1.7× 457 1.2× 268 0.8× 79 3.4k

Countries citing papers authored by Patricia Formento

Since Specialization
Citations

This map shows the geographic impact of Patricia Formento's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Formento with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Formento more than expected).

Fields of papers citing papers by Patricia Formento

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Formento. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Formento. The network helps show where Patricia Formento may publish in the future.

Co-authorship network of co-authors of Patricia Formento

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Formento. A scholar is included among the top collaborators of Patricia Formento based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Formento. Patricia Formento is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Milano, G., Patricia Formento, Sarah Giacometti, et al.. (2011). Positive interaction between lapatinib and capecitabine in human breast cancer models: study of molecular determinants. Fundamental and Clinical Pharmacology. 26(4). 530–537. 11 indexed citations
2.
Étienne-Grimaldi, Marie-Christine, Patricia Formento, Armelle Degeorges, et al.. (2010). Prospective analysis of the impact of VEGF‐A gene polymorphisms on the pharmacodynamics of bevacizumab‐based therapy in metastatic breast cancer patients. British Journal of Clinical Pharmacology. 71(6). 921–928. 56 indexed citations
3.
Bozec, Alexandre, Patricia Formento, Jean–Louis Fischel, Marie-Christine Étienne-Grimaldi, & G. Milano. (2010). Tapered dose versus constant drug exposure to anti-EGFR drugs on head-and-neck cancer xenografts. A comparison between cetuximab and gefitinib. Oral Oncology. 46(3). 172–177. 4 indexed citations
4.
Bozec, Alexandre, et al.. (2007). Dual inhibition of EGFR and VEGFR pathways in combination with irradiation: antitumour supra-additive effects on human head and neck cancer xenografts. British Journal of Cancer. 97(1). 65–72. 48 indexed citations
5.
Fischel, Jean–Louis, Jean-­Marc Ferrero, Patricia Formento, et al.. (2005). Taxotere???5???-deoxy-5-fluorouridine combination on hormone-refractory human prostate cancer cells. Anti-Cancer Drugs. 16(3). 309–316. 7 indexed citations
6.
Fischel, Jean–Louis, Patricia Formento, Joseph Ciccolini, Marie-Christine Étienne-Grimaldi, & G. Milano. (2004). Lack of contribution of dihydrofluorouracil and α-fluoro-β-alanine to the cytotoxicity of 5'-deoxy-5-fluorouridine on human keratinocytes. Anti-Cancer Drugs. 15(10). 969–974. 19 indexed citations
7.
Etienne, Marie‐Christine, Jean–Louis Formento, M Chazal, et al.. (2004). Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients. Pharmacogenetics. 14(12). 785–792. 114 indexed citations
8.
Formento, Patricia, Jean‐Michel Hannoun‐Lévi, Jean–Louis Fischel, et al.. (2004). Dual HER 1-2 targeting of hormone-refractory prostate cancer by ZD1839 and trastuzumab. European Journal of Cancer. 40(18). 2837–2844. 17 indexed citations
9.
Magné, Nicolas, J-L Fischel, Céline Tiffon, et al.. (2003). Molecular mechanisms underlying the interaction between ZD1839 (‘Iressa’) and cisplatin/5-fluorouracil. British Journal of Cancer. 89(3). 585–592. 66 indexed citations
10.
Magné, Nicolas, Jean–Louis Fischel, A Dubreuil, et al.. (2002). Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 (‘Iressa’). British Journal of Cancer. 86(9). 1518–1523. 134 indexed citations
11.
Milano, G., et al.. (1998). A clinically applicable assay for tumoral thymidylate synthase combining reverse transcriptase–PCR and High-performance liquid chromatography. European Journal of Cancer. 34(1). 182–187. 4 indexed citations
12.
Formento, Patricia, Philippe Rostagno, Jean–Louis Formento, et al.. (1998). Combination of irinotecan (CPT11) and 5-fluorouracil with an analysis of cellular determinants of drug activity. Biochemical Pharmacology. 56(10). 1315–1322. 60 indexed citations
13.
Fischel, Jean–Louis, M C Etienne, T Spector, et al.. (1995). Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation.. PubMed. 1(9). 991–6. 57 indexed citations
14.
Etienne, M C, S. Chéradame, Jean–Louis Fischel, et al.. (1995). Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.. Journal of Clinical Oncology. 13(7). 1663–1670. 256 indexed citations
15.
Lagrange, Jean‐Léon, et al.. (1993). Importance of the irradiation timing within a chemoradiotherapy sequence including cisplatin and 5-FU-folinic acid. Experimental results. European Journal of Cancer. 29(11). 1531–1535. 5 indexed citations
16.
Fischel, J-L, et al.. (1992). [Cytotoxic effects of the combination of a new nitrosourea, fotemustine, combined with 5-fluorouracil and folinic acid depend on the sequence of their administration].. PubMed. 79(1). 81–90. 1 indexed citations
17.
Bernard, Sophie, M C Etienne, J-L Fischel, Patricia Formento, & G. Milano. (1991). Critical factors for the reversal of methotrexate cytotoxicity by folinic acid. British Journal of Cancer. 63(2). 303–307. 10 indexed citations
18.
Etienne, M C, Jean–Louis Fischel, G. Milano, et al.. (1990). Steroid receptors in human osteoblast-like cells. European Journal of Cancer and Clinical Oncology. 26(7). 807–810. 29 indexed citations
19.
Olivier, Sabine, Patricia Formento, Jean–Louis Fischel, M C Etienne, & G. Milano. (1990). Epidermal growth factor receptor expression and suramin cytotoxicity in vitro. European Journal of Cancer and Clinical Oncology. 26(8). 867–871. 51 indexed citations
20.
Fischel, Jean–Louis, Patricia Formento, M C Etienne, et al.. (1990). In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea. Cancer Chemotherapy and Pharmacology. 25(5). 337–341. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026